ApprovalTrail

Approval · Notice of Compliance 15978 · 2014

LORAZEPAM: Notice of Compliance 15978

Issued August 21, 2014

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
15978
Date
August 21, 2014
Company
Sanis Health Inc.Brampton, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Licensing agreement between two companies
Therapeutic class
Anxiolytic - sedative

Products in this notice

BrandDINStatus today
LORAZEPAM02351072Cancelled Post Market
LORAZEPAM02351080Cancelled Post Market
LORAZEPAM02351099Cancelled Post Market

Medicinal ingredients